Tuspetinib selected for a prestigious national clinical research program for ability to target broad spectrum of AML and MDS populations Trials to test tuspetinib in targeted drug combinations for ...
Beclin-1: a therapeutic target at the intersection of autophagy, immunotherapy, and cancer treatment
Another element that controls autophagy in liver cancer is Oroxylin A. Oroxylin A was utilized to trigger Beclin 1-facilitated macroautophagy in the HepG2 cell line of human hepatocellular carcinoma.
Background: Autophagy promotes the survival of acute myeloid leukemia (AML) cells by removing damaged organelles and proteins and protecting them from stress-induced apoptosis. Although many studies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback